New York Endocrinology | Rocio Salas-Whalen, MD

New York Endocrinology, led by board-certified endocrinologist and obesity medicine specialist Rocio Salas-Whalen, MD, operates in New York, NY, delivering subspecialty care for metabolic and hormonal disorders. Dr. Salas-Whalen holds dual board certifications in endocrinology and obesity medicine, positioning the practice to address complex cases involving weight regulation, insulin resistance, thyroid dysfunction, and polycystic ovary syndrome (PCOS). The clinic serves patients throughout Manhattan and the greater New York metropolitan area with in-person consultations, allowing for comprehensive physical examinations and real-time diagnostic interpretation that support nuanced treatment decisions in endocrine care.

New York Endocrinology | Rocio Salas-Whalen, MD's peptide therapy menu includes Liraglutide, Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.

Dr. Salas-Whalen's clinical approach emphasizes evidence-based medicine informed by current endocrine society guidelines and emerging research in metabolic health. Her obesity medicine certification reflects specialized training in the pathophysiology of adiposity, behavioral modification strategies, and the pharmacologic management of weight-related comorbidities. The practice addresses women's health concerns including PCOS, a common endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and metabolic syndrome features. Treatment protocols for PCOS patients may combine GLP-1 therapies with insulin sensitizers, antiandrogens, and lifestyle interventions tailored to reproductive and metabolic goals. For diabetes management, the clinic provides continuous glucose monitoring interpretation, insulin regimen optimization, and cardiovascular risk stratification, recognizing that modern diabetes care extends beyond glycemic targets to encompass comprehensive cardiometabolic protection.

Patients attending New York Endocrinology undergo thorough initial evaluations that typically include detailed medical history review, physical examination with attention to body composition and endocrine-specific findings, and laboratory assessment of hormonal axes and metabolic markers. Follow-up visits track treatment response through objective measures—weight trends, A1c levels, lipid panels, thyroid function tests—and subjective parameters including energy, satiety, and quality of life indicators. The practice maintains a structured approach to GLP-1 therapy initiation, beginning with conservative doses to minimize gastrointestinal side effects and titrating based on individual tolerance and therapeutic targets. Patients receive education on injection technique, medication storage, and recognition of adverse effects, with clear protocols for managing nausea, constipation, or hypoglycemia. The clinic's focus on in-person care allows for hands-on teaching and immediate clinical assessment when questions or concerns arise during treatment.

With a 4.8-star rating across 140 Google reviews, New York Endocrinology has established a reputation for thorough evaluation and responsive patient communication. Review themes highlight efficient appointment scheduling, attentive clinical teams, and Dr. Salas-Whalen's ability to explain complex hormonal interactions in accessible terms. The practice's location in New York, NY, provides access to a patient population with diverse endocrine needs, from young women navigating PCOS and fertility concerns to older adults managing multiple metabolic conditions. The clinic's integration of advanced peptide therapies with traditional endocrinology reflects a modern approach to hormone-related disease, recognizing that conditions like obesity and diabetes require pharmacologic interventions that address underlying physiologic mechanisms rather than symptoms alone. For New York residents seeking subspecialty endocrine care with expertise in metabolic peptides, New York Endocrinology offers a practice model built on diagnostic precision and individualized therapeutic planning.